Zsofia Kote‐Jarai

38.8k total citations
92 papers, 3.0k citations indexed

About

Zsofia Kote‐Jarai is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zsofia Kote‐Jarai has authored 92 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Genetics, 42 papers in Pulmonary and Respiratory Medicine and 40 papers in Molecular Biology. Recurrent topics in Zsofia Kote‐Jarai's work include Prostate Cancer Treatment and Research (40 papers), BRCA gene mutations in cancer (25 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). Zsofia Kote‐Jarai is often cited by papers focused on Prostate Cancer Treatment and Research (40 papers), BRCA gene mutations in cancer (25 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). Zsofia Kote‐Jarai collaborates with scholars based in United Kingdom, United States and Canada. Zsofia Kote‐Jarai's co-authors include Rosalind A. Eeles, Douglas F. Easton, Chee Goh, Michelle Guy, Elizabeth Bancroft, Elena Castro, Edward J. Saunders, Tokhir Dadaev, Daniel Leongamornlert and Rosemary Wilkinson and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Zsofia Kote‐Jarai

88 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zsofia Kote‐Jarai 1.4k 1.3k 1.1k 667 649 92 3.0k
Elena Castro 876 0.6× 1.8k 1.4× 482 0.4× 1.1k 1.6× 729 1.1× 116 2.8k
Philip Jonsson 1.4k 1.0× 462 0.4× 485 0.4× 773 1.2× 902 1.4× 41 2.8k
Peter Broderick 1.8k 1.3× 475 0.4× 813 0.7× 548 0.8× 594 0.9× 51 3.0k
Athena Matakidou 1.6k 1.2× 751 0.6× 577 0.5× 833 1.2× 554 0.9× 39 2.9k
Emma R. Woodward 1.0k 0.7× 667 0.5× 947 0.9× 819 1.2× 1.1k 1.7× 104 3.2k
Hilmi Özçelik 2.3k 1.6× 347 0.3× 1.1k 1.0× 1.2k 1.8× 758 1.2× 79 3.6k
Jonathan D. Marotti 621 0.4× 510 0.4× 570 0.5× 1.3k 2.0× 1.1k 1.7× 84 2.5k
Pierre O. Chappuis 1.3k 0.9× 384 0.3× 1.4k 1.3× 1.7k 2.6× 1.5k 2.3× 107 3.6k
Ella Evron 2.4k 1.7× 330 0.3× 510 0.5× 928 1.4× 850 1.3× 65 3.5k
Edward D. Esplin 866 0.6× 349 0.3× 789 0.7× 522 0.8× 539 0.8× 118 2.0k

Countries citing papers authored by Zsofia Kote‐Jarai

Since Specialization
Citations

This map shows the geographic impact of Zsofia Kote‐Jarai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsofia Kote‐Jarai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsofia Kote‐Jarai more than expected).

Fields of papers citing papers by Zsofia Kote‐Jarai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsofia Kote‐Jarai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsofia Kote‐Jarai. The network helps show where Zsofia Kote‐Jarai may publish in the future.

Co-authorship network of co-authors of Zsofia Kote‐Jarai

This figure shows the co-authorship network connecting the top 25 collaborators of Zsofia Kote‐Jarai. A scholar is included among the top collaborators of Zsofia Kote‐Jarai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsofia Kote‐Jarai. Zsofia Kote‐Jarai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saunders, Edward J., Tokhir Dadaev, Mark N. Brook, et al.. (2024). Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European Urology Oncology. 7(2). 248–257. 3 indexed citations
2.
Mutambirwa, Shingai B.A., Zsofia Kote‐Jarai, Weerachai Jaratlerdsiri, et al.. (2023). Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer. Journal of the National Comprehensive Cancer Network. 21(3). 289–296.e3. 13 indexed citations
3.
Boonen, Rick A.C.M., Wouter W. Wiegant, Bas Vroling, et al.. (2021). Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk. Cancer Research. 82(4). 615–631. 33 indexed citations
4.
Wu, Lang, Xiang Shu, Jiandong Bao, et al.. (2019). Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk. Cancer Research. 79(18). 4592–4598. 16 indexed citations
5.
Wu, Lang, Jifeng Wang, Qiuyin Cai, et al.. (2019). Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants. Cancer Research. 79(13). 3192–3204. 37 indexed citations
6.
Callender, Thomas, Mark Emberton, Stephen Morris, et al.. (2019). Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study. PLoS Medicine. 16(12). e1002998–e1002998. 48 indexed citations
7.
Loveday, Chey, Amit Sud, Kevin Litchfield, et al.. (2019). Runs of homozygosity and testicular cancer risk. Andrology. 7(4). 555–564. 4 indexed citations
8.
Wu, Lang, Jirong Long, Yingchang Lu, et al.. (2017). Abstract 1301: Identification of novel susceptibility loci and genes for prostate cancer risk: A large transcriptome-wide association study in over 143,000 subjects. Cancer Research. 77(13_Supplement). 1301–1301. 1 indexed citations
9.
MacInnis, Robert J., Daniel F. Schmidt, Enes Makalic, et al.. (2016). Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 25(12). 1619–1624. 3 indexed citations
10.
Pashayan, Nora, Stephen Duffy, David E. Neal, et al.. (2015). Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genetics in Medicine. 17(10). 789–795. 69 indexed citations
11.
Castro, Elena, Sarah Jugurnauth-Little, Fátima Al‐Shahrour, et al.. (2015). High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers. Annals of Oncology. 26(11). 2293–2300. 25 indexed citations
12.
Knipe, Duleeka, David M. Evans, John P. Kemp, et al.. (2014). Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1356–1365. 25 indexed citations
13.
Orozco, Gisela, Chee Goh, Ali Amin Al Olama, et al.. (2012). Common genetic variants associated with disease from genome‐wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. British Journal of Urology. 111(7). 1148–1155. 9 indexed citations
14.
Killick, Emma, Elizabeth Bancroft, Zsofia Kote‐Jarai, & Rosalind A. Eeles. (2012). Beyond Prostate-specific Antigen — Future Biomarkers for the Early Detection and Management of Prostate Cancer. Clinical Oncology. 24(8). 545–555. 12 indexed citations
15.
Kote‐Jarai, Zsofia, Daniel Leongamornlert, Edward J. Saunders, et al.. (2011). BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. British Journal of Cancer. 105(8). 1230–1234. 256 indexed citations
16.
Kote‐Jarai, Zsofia, Daniel Leongamornlert, Malgorzata Tymrakiewicz, et al.. (2009). Mutation analysis of the MSMB gene in familial prostate cancer. British Journal of Cancer. 102(2). 414–418. 14 indexed citations
17.
Jhavar, Sameer, Alison Reid, Jeremy Clark, et al.. (2007). Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays. Journal of Molecular Diagnostics. 10(1). 50–57. 43 indexed citations
18.
Kadouri, Luna, Zsofia Kote‐Jarai, Douglas F. Easton, et al.. (2003). Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. International Journal of Cancer. 108(3). 399–403. 31 indexed citations
19.
Kote‐Jarai, Zsofia, S. Ashley, DF Easton, et al.. (2000). BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial. Breast Cancer Research. 2(S1). 1 indexed citations
20.
Burghes, Arthur H.M., Susan E. Ingraham, Michael J. McLean, et al.. (1994). A Multicopy Dinucleotide Marker That Maps Close to the Spinal Muscular Atrophy Gene. Genomics. 21(2). 394–402. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Castro Breakdown of academic impact, for papers by Philip Jonsson Breakdown of academic impact, for papers by Peter Broderick Breakdown of academic impact, for papers by Athena Matakidou Breakdown of academic impact, for papers by Emma R. Woodward Breakdown of academic impact, for papers by Hilmi Özçelik Breakdown of academic impact, for papers by Jonathan D. Marotti Breakdown of academic impact, for papers by Pierre O. Chappuis Breakdown of academic impact, for papers by Ella Evron Breakdown of academic impact, for papers by Edward D. Esplin
Rankless by CCL
2026